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When Group A streptococci are mixed with human blood under appropriate 
conditions in vitro, the bacteria are rapidly engulfed and killed by leucocytes. 
Among the conditions (1) required for this reaction are: (a)  sufficiently large 
numbers  of leucocytes, (b)  complement and  perhaps other serum  or plasma 
factors,  (c)  an  efficient mixing  system  to  ensure  adequate  opportunity for 
contact between the white cells and streptococci, and (d) type-specific antibody, 
which is necessary for phagocytosis only in  the case of streptococcal strains 
containing M  protein. 
Efforts  to  develop  an  opsonophagocytic  test  for  Group  A  streptococci, 
employing rabbit or mouse blood, have been "unsuccessful.  The lack of bacteri- 
cidal action in blood of these animals has been attributed by some to failure 
of  the  leucocytes to kill  engulfed microorganisms  (2,  3),  while  others  have 
implicated deficiencies in plasma factors and inadequate phagocytosis (1,  4). 
Furthermore, recent studies have demonstrated that  the differences between 
rabbit and human blood are not entirely consistent in this regard; blood from 
certain  apparently healthy  human  beings  is  not  satisfactory for use  in  the 
bactericidal  test  on  streptococci,  while  on  rare  occasions  a  rabbit  is  found 
whose blood serves quite well for this purpose (5). 
This communication presents studies on interactions between polymorpho- 
nuclear leucocytes and Group A streptococci in vitro. The results indicate that 
under certain conditions an anti-phagocytic effect is exerted by the strepto- 
coccal hyaluronic acid capsule as well as by M  protein. All human plasma or 
serum specimens thus far studied contain a factor, apparently neither enzyme 
nor antibody in nature, which counteracts the phagocytosis-resisting action of 
the capsule. In contrast, rabbit serum appears to be devoid of this factor. 
Methods 
Peritoneal exudates were collected from adult New Zealand Red rabbits by a technique 
previously described (6), with slight modifications. The essential features of this procedure 
were as follows. Three hundred ml. of sterile isotonic saline containing 1 rag. per ml. glycogen 
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(Amend Drug and Chemical Co. Inc., New York) were injected intrapefitoneally. Three to 
4 hours later, a  No.  15 perforated needle was inserted into the peritoneal cavity with the 
rabbit in the prone position. The exudate was allowed to flow by gravity into a flask con- 
taining  10 rag.  of heparin.  Ordinarily the  100  to  200  ml. of exudate  recovered contained 
approximately 5  X  10  a leucocytes per mm), of which over 95 per cent were polymorpho- 
nuclear ones. Cells were separated  from the exudate supernatant  fluid by spinning  (Inter- 
national centrifuge, size 2) at 1000 ~.p.xt. for 10 minutes. All operations were performed at 
room temperature. 
Streptococcal strains were kindly provided by Dr. Rebecca Lancefield. These were main- 
tained in the frozen state in small aliquots until time of use, and were then cultured in Todd- 
Hewitt broth to which was added a sterile solution of bovine albumin (fraction V) to a final 
concentration of 0.3 per cent. Young subcultures were made by inoculating 5 ml. of Todd- 
Hewitt albumin broth with 0.1  ml. of an 18 hour old culture. These subcultures were then 
used after 3 hours growth at 38°C.  Todd-Hewitt broth containing 10 per cent human serum, 
10 per cent rabbit serum, or 1 per cent defibrinated rabbit blood was also used for culturing 
the organisms in some experiments. 
Bactericidal tests were done in 10 X  75 ram. pyrex text tubes. After the white cells, dilut- 
ing fluids, and other test ingredients had been placed in these tubes to give the desired cell 
count in a volume of 0.9 nil., 0.1 ml. of approximately a 1:3000 dilution of the streptococcal 
culture was added. Streptococci were diluted in the suspending medium used for the bacte- 
ricidal test; initially this was the supernatant fluid from the rabbit peritoneal exudate, while 
later Gey's balanced salt solution containing 10 per cent rabbit serum was employed. The 
tubes were sealed with sterile rubber stoppers. Promptly after initial mixing an aliquot was 
removed for plate count of the numbers of streptococcal units in the test system. The tubes 
were then rotated end-over-end at 8 a.P.g, at 38°C.  At various time intervals aliquots were 
removed. Pour plates  (proteose agar containing 2 per cent defibrinated rabbit blood)  were 
made with measured volumes of the white ceil  streptococcal suspensions  and  of tenfold 
serial dilutions of these in Todd-Hewitt  broth. After overnight incubation at 38°C.,  colony 
counts permitted calculation of the number of surviving streptococcal units  per milliliter of 
original suspension. 
Antisera prepared in rabbits against certain streptococcal strains were kindly provided by 
Dr. Rebecca Laneefield. 
Observations were made on encapsulation of streptococci and on their phagocytosis in the 
leucocyte mixtures as follows. A loopful of the suspension to be studied was mixed on a clean 
slide with a loopful of a  1:5 dilution in saline of a finely divided, well dispersed  carbon sus- 
pension (Pelikan, Gunther-Wagner, Hannover, Germany). A coverslip was applied and the mix- 
ture examined under high power (X 450), utilizing phase contrast optics. Capsules were read- 
ily detected by this procedure and estimation could also be made of the number and  length 
of extracelinlar streptococcal chains. 
Bovine testicular hyaluronidase (Worthington Biochemical Corp., Freehold, New Jersey) 
was dissolved at 5 rag. per ml. in sterile isotonic saline and stored at 4°C. Appropriate quan- 
tities of this stock solution were added at the time of bactericidal testing. A fresh solution of 
hyaluronidase was made each week to minimize the effects of variable deterioration of activ- 
ity in the stock solution. 
Blood obtained from normal rabbits and healthy human beings was rimmed after dotting, 
incubated at 38°C. for 1 hour, and centrifuged. The serum, distributed in small aliquots and 
stored at --20°C., was used within 1 month of the time of collection. 
Human  leucocytes were obtained  from blood by the dextran  sedimentation  technique. 
Forty ml. of blood was drawn into a syringe previously moistened with 0.4 ml. of a  10 rag. 
per ml. solution of heparin. After addition of 2 ml. of 12 per cent dextran in water (Abbott J.  G.  HIRSCH  AND  A.  B.  CHURCH  311 
Laboratories,  Chicago) and mixing, sedimentation  was allowed to proceed in 15 X  150 mm. 
test tubes for 2 hours at room temperature.  The supernatant cell-rich plasma layer was then 
removed and spun at 500 R.l,,~r. (International Centrifuge, size 2) for 10 minutes, bringing 
down cells but leaving most of the platelets in suspension. The cell button was washed twice 
with isotonic saline in the centrifuge and then suspended in 10 ml. of saline for total and wet 
differential counts. 
RESULTS 
The Fate in Vitro in Rabbit Peritoneal Exudates of Streptococci from Young and 
Old Cultures 
The  early  experiments  were  performed  by  adding  streptococci  to  rabbit 
peritoneal  exudates and observing the fate of the bacteria on mixing in vitro. 
TABLE I 
Fate of Various Group A  Streptococci on Mixing  in  Vitro with Rabbit Peritoneal Exudates 
Type and strain of Group A streptococcus 
Type 3, D58x (R  +) 
"  , B930/24 (R-) 
"  D121  (R  ~) 
Type 4, C748. 
"  ,  cls5/5. 
Type 22, B401. 
"  , T22/117.. 
Type 6, S43MA. 
"  S43FL. 
"  $43G. 
"  B410. 
Hyaluroni- 
dsse 
production 
0 
0 
0 
+ 
0 
+ 
+ 
0 
0 
0 
0 
M 
protein 
o 
+ 
+ 
o 
o 
o 
o 
o 
+ 
o 
+ 
Capsule 
formation in 
young 
cultures 
+ 
+ 
+ 
o 
o 
0 
0 
+ 
+ 
0 
0 
Killing  in rabbit 
phagocytic  system of 
Young  Old ~lShr.' 
(3 hr.)  cultures  cultures 
o  + 
o  + 
o  + 
+  + 
+  + 
+  + 
+  + 
o  + 
o  + 
+  + 
+  + 
The concentration of granulocytes in each experiment was adjusted  to 25,000 
per ram3 (over 95 per cent polymorphonuclears) by centrifuging the cells and 
resuspending them in an appropriate volume of the supernatant fluid. Initially 
18 hour old cultures  of various streptococcal strains  were used;  all strains  so 
studied were killed on mixing with rabbit peritoneal exudates. However, 3 hour 
old subcultures of several of these strains multiplied in the same test system. 
Results  of  these  experiments  do  not  warrant  detailed  presentation,  but  are 
summarized  in  Table  I.  It is  seen  that  there  was  good correlation  between 
resistance  to killing and the presence of a  capsule. 
In these experiments,  as well as in those to be discussed in later sections of 
this  report,  specimens  were  frequently  included  in  which  tubes  were  held 
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white cells were omitted. In every instance streptococci grew in these controls, 
indicating that bactericidal  activity, when observed, was due to phagocytosis 
and intraceUular killing. 
The results  shown in Table I  suggested, but by no means established,  that 
hyaluronic acid capsules rendered Group A streptococci relatively resistant to 
engulfment by rabbit polymorphonuclear  leucocytes. Obviously young cultures 
might differ from old ones in many ways in addition to encapsulation.  Further 
experiments  were done in which a single streptococcal  culture was tested for 
susceptibility to phagocytosis  at 30 minute intervals throughout its growth; 
under the conditions  used,  resistance  to killing in the rabbit exudate system 
appeared at about hour I and disappeared at about hour 6 of the growth cycle. 
Microscopic observations revealed that this coincided precisely with the period 
during which capsules were visible. 
Subcultures  of streptococci  in broth containing a final concentration of 100 
vg.  hyaluronidase per  ml.  of medium remained unencapsulated throughout 
their growth cycle. Three hour old subcultures  in hyaluronidase-broth mani- 
fested resistance to phagocytosis and killing similar to that of the young cultures 
grown in ordinary Todd-Hewitt broth. This at first suggested that hyaluronic 
acid capsule was not the important anti-phagocytic  factor of the young cultures. 
However, microscopic studies revealed  that the 3 hour old subcultures  grown 
in the presence  of hyaluronidase, although devoid of capsule at the time of 
addition to the rabbit exudate test system, rapidly became fully encapsulated 
after transfer to this system, large capsules being visible within l0 minutes of 
transfer. This finding  indicated that hyaluronidase activity in the final  test 
system was necessary for reliable appraisal of the relationship between encapsu- 
lation and resistance to phagocytosis. 
The  Effects  of Hyaluronidase  and  of Antiserum  on  Susceptibility  of  Various 
Strains  of Streptococci to Pkagocytosis by Suspensions  of Rabbit Granulocytes 
The supernatant exudate fluid varied considerably from time to time in its 
ability to antagonize hyaluronidase activity. Therefore the suspending medium 
for opsonophagocytic  tests was changed  to a  balanced salt solution  (Gey's) 
containing 10 per cent fresh serum.  It was noted that serum concentrations 
lower than 10 per cent did not regularly allow phagocytosis  at maximal rate, 
presumably because of the requirement for complement in this process. On the 
other hand, systems containing more than 20 per cent serum manifested  variable 
inhibition of hyaluronidase at the concentration of this enzyme (100 t~g. per 
ml.) employed in the test. All experiments  discussed in this section were done 
on 3 hour old subcultures  of streptococci.  Washed rabbit peritoneal exudate 
granulocytes were present  at 25,000 per  mm.  3.  Additions  made to  this  test 
system  in  each  experiment  included  homologous  antiserum,  heterologous 
antiserum, and hyaluronidase in various combinations. o  I 
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FIO. I. The influence  of hyaluronidase and of antiserum on the fate of various type 6 strepto- 
cocci  mixed in ~#o with suspensions of rabbit  polymorphonuclcar leucocytes. 
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FIG. 2. The influence  of hyalnronidase  and of antiserum on the fate  of various type 3 
streptococci mixed in dtro with suspensions of rabbit polymorphonuclear leucocytes. 
Fig.  1 shows the results of phagocytosis-bactericidal tests on several strains 
of type 6 streptococci. The non-capsulated strains, B410t(M  +) and $43G (M-), 
were both killed without addition of antiserum or hyaluronidase. In contrast, 
the  encapsulated  strains  S43MV~(M  +)  and  S43MA  (M-)  multiplied  in  the 
basal test system and in those specimens containing type 3 or type 6 antiserum, 
Strain B410 contained only small amounts of M protein detectable in precipitin tests, 
whereas strains S43MV and $43/100 yielded extracts with large and approximately equal 
quantities of M substance. Only $43/100 among these strains was highly virulent for mice. J.  G.  HIRSCH  AND  A.  B.  CHURCH  315 
while addition of hyaluronidase, with or without either antiserum, led to killing. 
The encapsulated strain $43/1001(M +)  exhibited somewhat different behavior, 
growing in the unmodified test system and in the presence of added heterologous 
antiserum,  while  addition  of  homologous  antiserum  resulted  in  moderate 
bactericidal action. Hyaluronidase alone or in combination with type 3 anti- 
serum  also  led  to  moderate  killing  of  $43/100.  The  combined  addition  of 
hyaluronidase and type 6 antiserum resulted in most efficient  elimination  of 
this strain. 
Results of similar studies on type 3 strains of Group A streptococci are shown 
in Fig. 2. These were done to confirm  the findings  obtained with the type 6 
strains, and also to investigate the possible role of R antigen in this phagocytic 
system.  Strain  D58X  (M-,  R +,  encapsulated)  multiplied  in  the presence of 
either type 3 or 6 antiserum, while the numbers of surviving streptococcal units 
were markedly reduced when hyaluronidase or combinations of hyaluronidase 
and either antiserum were added. Strain B930/24~(M +, R-, encapsulated) also 
grew in the control test system with no additions,  and this growth was not 
influenced by addition of homologous or heterologous antiserum. Hyaluronidase 
alone or hyaluronidase plus type 6 antiserum led to a moderate lethal effect, 
while addition of both hyaluronidase and type 3 antiserum resulted in marked 
killing.  Strain D58X/ll/1~(M  +, encapsulated) increased in numbers when no 
additions were made to the system and also when heterologous antiserum was 
added,  while  homologous  antiserum  brought  about  moderate  killing.  The 
numbers  of  viable  streptococcal  units  remained  rdatively  constant  in  the 
presence  of  hyaluronidase  with  or  without  type  6  antiserum.  Addition  of 
hyaluronidase and type 3 antiserum to the test system led to rapid and complete 
elimination  of  this  strain.  In  the  figure  presenting  results  with  strain 
D58X/ll/1,  enumeration of bacteria is recorded at frequent intervals during 
the experiment, rather than only at the outset and at 90 minutes. The curves 
so obtained  show the  rapidity  with  which  phagocytosis and  killing  can  be 
accomplished provided conditions are optimal for these processes. 
Several  other  observations,  not  shown  in  the  figures,  were  made  in  the 
course of these experiments. Hyaluronidase solutions heated at 100°C. for 10 
minutes lost completely their capacity to promote phagocytosis of streptococci. 
Addition of other basic proteins,  such as lysozyme and ribonuclease,  did not 
lead to engulfment of encapsulated streptococci by rabbit leucocytes. Strepto- 
coccal subcultures in Todd-Hewitt broth containing 10 per cent human, rabbit 
or bovine serum, or 1 per cent rabbit blood behaved the same as those grown 
in Todd-Hewitt albumin broth. 
Both strains B930/24  and D58X/11/1  contained large amounts of M  protein as meas- 
ured in precipitin tests, and both were virulent for mice. 316  PHAGOCYTOSIS  O~'  STREPTOCOCCI 
Comparison  of Human and Rabbit  Leucocytes and Serum in Their Capacity to 
Promote  Phagocytosis  and  Killing  of Group  A  Streptococci 
It  thus seemed clear  that encapsulated streptococci resisted  phagocytosis 
in  the rabbit leucocyte-rabbit serum  system.  Further  studies were required 
to determine whether or not this phenomenon bore any relation to the known 
difference between rabbit  and human blood in  their suitability for opsono- 
phagocytic tests for detection of type-specific streptococcal antibodies. In these 
experiments an encapsulated, M- streptococcal strain, S43MA, was employed 
so as to permit evaluation of the anti-phagocytic role of the capsule uncom- 
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FIo. 3. Comparison  of human and rabbit leucocytes  in their capacity to destroy encapsu- 
lated streptococci in vitro in a medium containing  rabbit serum. 
plicated by additional similar effects of M  protein. Young subcultures of this 
strain  were  added  to  suspensions  of human or  rabbit  white cells  in  Gey's 
solution  containing human  or  rabbit  serum,  and  fate  of  the  bacteria  was 
determined on mixing at 38°C.  Human leucocytes were prepared from blood 
by the dextran sedimentation technique (see Methods). 
The results shown in Fig. 3 indicate that rabbit and human white cells did 
not differ in their capacity to engulf and destroy streptococci. In a  medium 
containing 10 per cent rabbit serum, neither human nor rabbit leucocytes were 
able to kill the test microbes efficiently unless hyaluronidase was added to the 
system. In the presence of hyaluronidase, both cell types handled the strepto- 
cocci in essentially identical fashion. No clumping or other detectable damage 
to human leucocytes was evident in the presence of rabbit serum. 
Fig. 4 presents results of a  similar experiment in which 10 per cent human J.  G.  HIRSCH  AND  A.  B.  CHURCH  317 
serum in Gey's solution was employed as the suspending medium. Meaningful 
results could not be obtained using rabbit white cells in this test system, since 
they were  promptly  agglutinated when  suspended in  a  medium containing 
human serum. Several human sera from each of the ABO blood groups were 
used, but each produced extensive damage to rabbit white cells as evidenced by 
clumping and permeability to trypan blue. Human leucocytes were not clumped 
or otherwise detectably damaged, and,  as is  shown in  Fig. 4,  accomplished 
slight killing of the streptococci. The lethal action was considerably enhanced 
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FIG. 4. The influence  of hyaluronidase  on the phagocytosis in vitro of encapsulated  strep- 
tococci by human leucocytes in a system containing 10 per cent human serum. 
by  addition  of hyaluronidase, showing that  in  this  particular  human  cell- 
human serum system, streptococcal capsules exerted an anti-phagocytic effect. 
The slight killing of streptococci by human leucocytes in the 10 per cent human 
serum medium suggested that a  capsule-neutralizing factor might be present 
in limited amounts in human serum, and that higher serum concentrations 
might be required for its unequivocal demonstration. 
Further experiments were therefore done employing human leucocytes and 
various concentrations of fresh serum from the same person. These were carried 
out in a medium containing 10 per cent fresh rabbit serum to provide adequate 
complement. The results of a typical study are shown in Fig. 5. Clearly demon- 
strated is the role of human serum in promoting phagocytosis of this encap- 
sulated, M- streptococcus. At concentrations of human serum lower than 10 
per cent, the bacteria were not engulfed and hence multiplied. Ten per cent 318  PIIAGOCYTOSIS  OF  STREPTOCOCCI 
human serum in  the  system resulted in  an  essentially steady streptococcal 
population, with the rates of phagocytosis and extracellular growth approxi- 
mately balancing each other. At concentrations of human serum of 30 per cent 
or greater, rapid phagocytosis and killing of the microbes was seen, the degree 
of this phagocytosis-promoting action being, in fact, even more striking than 
that resulting from addition of hyaluronidase to the medium. 
In contrast, addition of rabbit serum in concentrations as  high as  90  per 
cent failed to promote phagocytosis of the streptococci. 
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Fro.  5.  Demonstration that a  factor  promoting phagocytosis  in  vitro of  encapsulated 
streptococci by human leucocytes is present in fresh human serum, but absent in rabbit 
serum and in heated human serum. 
Only a  few properties have been determined for the human serum factor 
which  promoted phagocytosis of  encapsulated  streptococci.  As  is  shown  in 
Fig. 5,  heating at 56°C.  for 30 minutes destroyed the activity. Heparinized 
plasma served as well as serum in the phagocytosis tests while pooled human 
gamma globulin (Ledefle) was without effect. No differences were found in the 
course of encapsulation of streptococci incubated in rabbit  and human sera 
which were,  respectively, ineffective and effective in rendering encapsulated 
streptococci  susceptible  to  phagocytosis.  Human  serum  did  not  produce 
detectable swelling or lysis of the capsules. 
There may be a  significant difference among individuals in the amount of 
the capsule-neutralizing factor contained in their serum.  With the 3 human 
sera  thus far studied,  the concentration required for opsonization of encap- J.  G.  ttIRSCH  AND  A.  B.  CHIYRCH  319 
sulated/vi- streptococci  was less than 5 per cent, 10 to 20 per cent, and 40 
per cent, respectively.  Ten rabbit sera have been investigated, and none con- 
tained measurable  amounts of this phagocytosis-promoting  factor. 
DISCUSSION 
Many previous  investigators have  inquired  into  the  differences  between 
human blood and that of rabbits or mice in relation to their capacity to kill 
Group  A  streptococci  in  vitro  (1-5).  Most  observations  show  that,  in  the 
presence  of homologous type antibody, virulent,  M  +  streptococci  are killed 
on mixing with fresh human blood, but survive or multiply in mouse or rabbit 
blood;  similarly  avirulent M- strains are destroyed by human blood  even in 
the absence of antibody, whereas they often grow in animal blood. The notion 
that this behavior might reflect  differences in the ability of leucocytes  from 
various species to kill ingested streptococci  (2, 3) seems to have been disproved 
by studies of Rothbard (1) and Wilson a  al.  (7), as well as by the results pre- 
sented  in  this  communication.  Previous  investigations have  also  excluded 
differences in numbers of leucocytes as the explanation for variation in strepto- 
coccicidal activity of blood  from various animals  (3,  4).  Furthermore, rates 
of proliferation of streptococci in serum or heated blood from man and animals 
are not significantly different (4). Thus, as concluded recently by Wiley (4), 
the rate of engulfment of streptococci  by leucocytes in human blood must be 
more  rapid than that in mouse  or rabbit blood.  Our  investigation supports 
this conclusion, and also confirms and extends the earlier studies of Rothbard 
(1),  in  which  the  rapid  phagocytosis  of  streptococci  in  human blood  was 
attributed to a  serum factor of unknown nature. The results presented here 
indicate moreover  the probable  reason  for accelerated  engulfment of  strep- 
tococci in human blood  as compared  to that in rabbit blood.  Human serum 
contains a factor which counteracts the anti-phagocytic effect of streptococcal 
hyaluronic acid capsules,  whereas  rabbit  serum  lacks  this factor. 
The anti-phagocytic activity of streptococcal  hyaluronic acid capsules has 
been demonstrated previously (8-11).  Evidence obtained in the present studies 
to support this concept is of two types. Firstly, there was correlation between 
presence  of capsules  among various strains or during the growth cycle of a 
given strain and resistance  to engulfment by rabbit  white cells in  vitro.  Sec- 
ondly, the use of hyaluronidase under conditions appropriate for its enzymatic 
action resulted in markedly increased  susceptibility to phagocytosis.  Heated 
solutions of hyaluronidase had no effect on phagocytosis,  nor did solutions of 
other  basic  proteins  such  as  lysozyme or  ribonuclease,  suggesting  that  hy- 
aluronidase acted in the system by virtue of its ability to strip off the capsule, 
and not by simple combination with the surface and non-specific opsonization. 
The influence of type-specific antibody on phagocytosis  of M  + streptococci 
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specific  antibody  led  to  engulfment  and  moderate  killing  of  some  strains 
(DS8X/ll/1  and  $43/100),  whereas  other  M +  strains  (B410,  S43MV,  and 
B930/24) and all M- encapsulated strains  resisted phagocytosis even in the 
presence of antibody. This behavior might be dependent on the quantity and/or 
location of M protein in the bacterial cells. If some strains contain large amounts 
of M protein located at or near the surface,  combination of antibody with this 
antigen might result in effective opsonization and masking of the hyaluronic 
acid capsule.  On the other hand, strains with little or no M protein accessible 
at the surface might well combine with insufficient antibody to coat the surface 
effectively, in which event the capsule would continue to exert its anti-phago- 
cytic effect. 
One technical aspect necessary for success  of these studies was the choice 
of a suitable test medium. Hyaluronidase added to broth cultures of streptococci 
prevented  the  appearance  of visible capsule,  but  organisms  so grown  very 
rapidly became fully encapsulated on transfer to a blood or exudate medium. 
Effective elimination of streptococcal capsules during phagocytic tests required 
hyaluronidase in an active form in the final test system. Serum concentration 
of the medium thus became critical; too much serum antagonized hyaluronidase, 
while  too little  provided inadequate  complement. 
A role for the hyaluronic acid capsule in influencing  susceptibility of strep- 
tococci to phagocytosis in vitro in no way conflicts  with or detracts from the 
well established function of M protein in this regard (1, 11, 12). It is apparent 
that  some streptococci possess two surface components,  M  protein  and  hy- 
aluronic acid,  either or both of which are able to protect the bacteria from 
engulfment  by  leucocytes under  certain  conditions.  The  recent  studies  of 
Foley and Wood (11) show that both M protein and hyaluronic acid capsules 
also  exert  anti-phagocytic  effects  when  tested  under  surface  phagocytosis 
conditions. 
The nature of the factor in human serum which counteracts the anti-phago- 
cytic effects of streptococcal capsules remains uncertain.  The lack of activity 
of pooled concentrated human  gamma globulin,  and  the heat lability of the 
serum factor make it unlikely that an antibody to hyaluronic acid is at work. 
Streptococci develop capsules  well  in  human  serum,  so  that  no  enzymatic 
action similar  to that of hyaluronidase is present to explain  the phenomenon. 
It  is  tempting  in  view of the heat  lability to attribute  to  complement  the 
opsonizing  action of human serum on encapsulated streptococci. Quantitative 
differences  between human  and  rabbit  serum  in  their  complement  content, 
at least as measured in hemolysis tests,  is not great;  qualitative  differences 
in complement from various animal species have been demonstrated,  but no 
information is available on their importance in the phagocytic process. 
The number of human sera thus far studied is small, and no statements can 
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age,  genetic background,  or history of previous streptococcal or other infec- 
tions. 
SUMMARY 
Studies have been made on phagocytosis and killing of Group A streptococci 
during mixing with suspensions of leucocytes in vitro. Under appropriate test 
conditions an anti-phagocytic effect can be demonstrated for the streptococcal 
hyaluronic acid capsule as well as for its M  protein. 
The results obtained suggest  an explanation for the suitability of human, 
but not  rabbit,  blood for opsonophagocyfic tests designed to  measure  type- 
specific streptococcal antibodies. Human sera contain a factor which counteracts 
the  anti-phagocytic  effects  of  streptococcal  hyaluronic  acid  capsules,  and 
hence  human  blood  serves  well  for  detection  of  antibodies  which  combine 
with the only other phagocytosis-resisting component of this microorganism, 
namely M  protein. In  contrast, rabbit sera contain none of this factor, and 
addition  of  antibody  to  M  protein  to  phagocytic  test  systems  employing 
rabbit  serum  does not  necessarily render the  streptococci susceptible to en- 
gulfment by white  cells,  since  the hyaluronic acid  capsule may continue to 
interfere with phagocytosis. 
The nature of the human serum factor which opsonizes encapsulated strep- 
tococci is unknown. It does not appear to be an antibody or an enzyme capable 
of depolymerizing hyaluronic acid. 
The authors wish to express their gratitude to Dr. Rebecca Lancefield for her valuable 
advice and for her kindness in providing the cultures and antlsera employed  in this study. 
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